Skip to main content

Table 1 Characteristics of participants

From: A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

  Group 1 Hexavac® Group 2 Infanrix Hexa® p-value
Number 113 124 -
Females, No (%) 44 (38.9) 58 (46.8) 0.2240
Mean age in months (± SD) 26.9 (± 1.2) 26.5 (± 1.3) 0.0232
Mean time in months since the third dose (± SD) 15.8 (± 0.9) 15.3 (± 1.5) 0.0093
Mean birth weight in grams (± SD) 3194.6 (± 560.8) 3233.2 (± 435.3) 0.9116
Mean gestational age in weeks (± SD), 39.3 (± 1.8) 39.2 (± 1.5) 0.4420
Vaccinees with MPR (%) 104 (92.1) 124 (100.0) 0.0010